Showing results (511-520 of 884) with videos related to
Sort By:
Pageof 89
Inflammatory Bowel Diseases|May 3, 2018
Outcomes of Endoscopic Therapy for Luminal Strictures in Crohn's DiseaseRaina Shivashankar, Jithinraj Edakkanambeth Varayil, W Scott Harmsen, et al.Inflammatory Bowel Diseases|September 30, 2010
Measurement of disease activity in ulcerative colitis: interobserver agreement and predictors of severityKelvin T Thia, Edward V Loftus, Darrell S Pardi, et al.Inflammatory Bowel Diseases|September 18, 2010
Adalimumab for Crohn's disease in clinical practice at Mayo clinic: the first 118 patientsJason M Swoger, Edward V Loftus, William J Tremaine, et al.Gut|December 1, 2006
The epidemiology of microscopic colitis: a population based study in Olmsted County, MinnesotaDarrell S Pardi, Edward V Loftus, Thomas C Smyrk, et al.Inflammatory Bowel Diseases|October 10, 2013
Comparative outcomes of younger and older hospitalized patients with inflammatory bowel disease treated with corticosteroidsNicholas K Weber, David H Bruining, Edward V Loftus, et al.Journal of the American College of Surgeons|May 8, 2007
Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitisChelliah R Selvasekar, Robert R Cima, David W Larson, et al.Archives of Surgery (Chicago, Ill. : 1960)|January 20, 2010
Recurrence and impact of postoperative prophylaxis in laparoscopically treated primary ileocolic Crohn diseaseKishore Malireddy, David W Larson, William J Sandborn, et al.Gastro Hep Advances|April 7, 2025
Effect of Risankizumab Induction and Maintenance Therapy on the Rate of Hospitalization in Patients with Crohn's DiseaseBrian G Feagan, Remo Panaccione, Stefan Schreiber, et al.Journal of Crohn'S & Colitis|November 27, 2020
Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical ProgrammeKevin L Winthrop, Edward V Loftus, Daniel C Baumgart, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 21, 2019
Comparative Efficacy and Speed of Onset of Action of Infliximab vs Golimumab in Ulcerative ColitisSiddharth Singh, James A Proudfoot, Parambir S Dulai, et al.Pageof 89